NS
TCRT icon

NBC Securities’s Alaunos Therapeutics TCRT Stock Holding History

NBC Securities’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45 Hold
20
– – ﹤0.01% 2408
2026
Q1 		$57 Hold
20
– – ﹤0.01% 2522
2025
Q4 		$64 Hold
20
– – ﹤0.01% 2756
2025
Q3 		$48 Buy
+20
New +$57 ﹤0.01% 2754
2024
Q2 		– Sell
-20
Closed -$1K – 2198
2024
Q1 		$1K Buy
+20
New +$400 ﹤0.01% 2136
2023
Q4 		– Sell
-20
Closed – – 2222
2023
Q3 		$0 Buy
+20
New +$862 ﹤0.01% 2174

Other funds holding TCRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NBC Securities's TCRT Position: Q2 2026 in Review

NBC Securities held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 20 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

NBC Securities first reported a position in TCRT in Q3 2023 and has held it in 6 quarters since. The position peaked at $1K in Q1 2024. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • NBC Securities held 20 shares of Alaunos Therapeutics worth $45 as of Q2 2026.
  • NBC Securities left its Alaunos Therapeutics share count unchanged in Q2 2026.
  • Alaunos Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2408 holding.
  • NBC Securities first reported a position in Alaunos Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • NBC Securities's Alaunos Therapeutics position peaked at $1K in Q1 2024.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.